Search research articles
Contact Us
Filters
Showing results (121-130 of 128) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 128 results.
The Lancet. Respiratory Medicine
|
September 27, 2020
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform
Anna Schultze, Alex J Walker, Brian MacKenna, et al.
BMC Medicine
|
July 5, 2022
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY
, Amelia Green, Helen Curtis, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
March 19, 2021
Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February
Daniel J Grint, Kevin Wing, Elizabeth Williamson, et al.
Free Radical Biology & Medicine
|
July 22, 2010
Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis
Eline Thomson, Siobhain Brennan, Revathy Senthilmohan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 6, 2021
Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England
Daniel J Grint, Kevin Wing, Catherine Houlihan, et al.
Thrombosis Research
|
February 15, 2022
Potentially inappropriate prescribing of DOACs to people with mechanical heart valves: A federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY
, Louis Fisher, Victoria Speed, et al.
Wellcome Open Research
|
May 31, 2022
A comprehensive high cost drugs dataset from the NHS in England - An OpenSAFELY-TPP Short Data Report
Anna Rowan, Chris Bates, William Hulme, et al.
The Lancet. Rheumatology
|
June 14, 2022
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform
Brian MacKenna, Nicholas A Kennedy, Amir Mehrkar, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 128) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 128 results.
The Lancet. Respiratory Medicine
|
September 27, 2020
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform
Anna Schultze, Alex J Walker, Brian MacKenna, et al.
BMC Medicine
|
July 5, 2022
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY
, Amelia Green, Helen Curtis, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
March 19, 2021
Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February
Daniel J Grint, Kevin Wing, Elizabeth Williamson, et al.
Free Radical Biology & Medicine
|
July 22, 2010
Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis
Eline Thomson, Siobhain Brennan, Revathy Senthilmohan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 6, 2021
Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England
Daniel J Grint, Kevin Wing, Catherine Houlihan, et al.
Thrombosis Research
|
February 15, 2022
Potentially inappropriate prescribing of DOACs to people with mechanical heart valves: A federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY
, Louis Fisher, Victoria Speed, et al.
Wellcome Open Research
|
May 31, 2022
A comprehensive high cost drugs dataset from the NHS in England - An OpenSAFELY-TPP Short Data Report
Anna Rowan, Chris Bates, William Hulme, et al.
The Lancet. Rheumatology
|
June 14, 2022
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform
Brian MacKenna, Nicholas A Kennedy, Amir Mehrkar, et al.
Page
of 13